Skip to content

Adam M Veness, SVP, General Counsel and Sec. at Dianthus Therapeutics, sold DNTH on Jun 17, 2026

Data as of Oct 16

▼ SELL$1.1M13,229 shares at $81.38Adam M Veness SVP, General Counsel and Sec.DNTH Dianthus Therapeutics, Inc.
Watch DNTH
Traded
Jun 17, 2026
Disclosed
Jun 18, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Adam M Veness, SVP, General Counsel and Sec. at Dianthus Therapeutics, sold DNTH on Jun 17, 2026TRADEDDISCLOSED
DNTHSimilar stocks (XLV — its sector index fund), rebased to DNTH's price on the disclosure day
DNTH since disclosure
−12.6%
after the sale
Similar stocks (XLV) since disclosure
+18.3%
XLV — its sector index fund

Change in closing price from Jun 18, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLAdam M Veness SVP, General Counsel and Sec.DNTH Dianthus Therapeutics, Inc.$1.3Mdisclosed Jun 18 · filed 1 day after the trade

See every trade on DNTH →